Why the study?
CVD risk prediction is critical for healthcare systems, but information evaluating these models in the Middle East has been limited.
Do the Globorisk and SCORE models accurately predict cardiovascular disease mortality in a Middle Eastern population?
Population
24 427 participants aged 40-80 years from four cohorts in Iran
Comparison
Globorisk vs SCORE risk prediction models
Design
Four population-based cohort studies
Follow-up
154 522 person-years
Authors
Loading...
Overestimation by original SCORE/Globorisk may prompt unnecessary interventions in Iran; leaves open need for region-specific recalibration in Middle Eastern cohorts.
Do the Globorisk and SCORE models accurately predict cardiovascular disease mortality in a Middle Eastern population?
Original Globorisk and SCORE models overestimate CVD risk in Iranian populations and require recalibration to accurately predict CVD mortality.
Fahimfar et al. (2020) studied this question.